• Chronic pain and psychiatric disorders frequently co-occur, and several studies suggest that there is a strong association between chronic pain and depression. [1] [2] • Given the strong link between chronic pain and depression, it is important to have highly sensitive and specific screening tools for depression in a chronic pain population for research purposes and clinical care.
• The Short Form-36 health survey (SF-36v2) is a widely used patient-reported measure that is useful in assessing health status and monitoring outcomes across both general and specific patient populations.
• Previous publications in the literature across different subgroups have supported the use of the SF-36 as a tool to classify patients with depression across different patient populations. [3] [4] [5] [6] [7] The expanded utility of the SF-36v2 to classify patients with chronic pain as depressed or nondepressed has not been studied.
Objective
• To assess the feasibility of the SF-36v2 Mental Health (MH) domain and Mental Component Summary (MCS) scores in the classification of risk for Major Depressive Disorder (MDD), and to determine the appropriate cut-off scores based on the sensitivity and specificity in a US representative sample overall, and in a chronic pain subpopulation.
Methods
Data Source
• Self-reported data from the 2013 US National Health and Wellness Survey (NHWS) dataset were used for this study (N = 75,000).
• The NHWS is an annual cross-sectional, Internet-based questionnaire administered in the English language to a sample of adults (aged 18 years or older) previously identified through web-based panels (Lightspeed Research Panelists). Invitations to participate in the NHWS were sent using a random stratified sampling framework to ensure the final sample of NHWS participants is representative of the adult population in the US.
• All NHWS respondents provided informed consent prior to participation. The NHWS study protocol including the informed consent was reviewed and approved by an institutional review board (Essex IRB, Lebanon, NJ, USA).
Inclusion Criteria
• Chronic pain subpopulation included:
Experiencing pain in the past month Experiencing pain for at least three months Currently taking a prescription medication for their pain
Measures
• Sociodemographics and health history variables including age, race/ethnicity, gender, education, employment status, body mass index (BMI), alcohol consumption, exercise behavior, smoking status, and the Charlson comorbidity index (CCI) were assessed.
• Patient-reported outcome measures including the Patient Health Questionnaire (PHQ-9) and the SF-36v2 were also completed as part of the NHWS.
The PHQ-9 is a patient-reported measure for screening, diagnosing, monitoring, and measuring the severity of depression developed to map to the nine criteria of the DSM-IV. 8 Each item is scored from 0 to 4 (total score 0 to 27), with higher scores indicating greater depression symptoms. PHQ-9 scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe, and severe depression, respectively. PHQ-9 scores ≥10 indicate risk of major depressive disorder.
The SF-36v2 is a patient-reported measure used to assess general health status and well-being over the past four weeks. 
Statistical Analysis
• In the primary analysis, depression was defined as the risk of MDD, corresponding to a PHQ-9 cut-off of ≥10; however, multiple definitions were used to predict depression from the SF-36v2 to help provide confirmatory evidence of the cut-off score selected.
• Descriptive statistics were used to describe the participants' sociodemographic characteristics, behavioral factors, comorbidity burden, and scores on the PHQ-9 and SF-36v2.
For categorical data, frequencies and percentages were reported; whereas means, and standard deviations, were reported for all continuous measures.
• Logistic regression modeling was used to predict each depression standard score (e.g., PHQ-9 score of ≥10 vs. PHQ-9 score of <10) from each depression proxy measure (e.g., MH domain score).
• Receiver Operating Characteristic (ROC) curves for each were also produced along with the area under the curve (AUC) to determine the accuracy of each proxy measure. The cut-off point for each measure was determined using the minimum distance method, selecting the score with the minimum distance to optimize sensitivity and specificity.
• To ensure that the cut-off scores were not sample-specific and the results were sufficiently stable across different samples, the dataset was split in half to cross-validate the current analysis in both datasets.
Results
• Respondents with chronic pain had less education, were less likely to be employed, and were more likely to smoke than the total NHWS sample.
• Mean comorbidity burden was 0.4 for the total sample and 1.0 among those with chronic pain. • Respondents in the total study sample had average SF-36v2 PCS scores of 50.3 and average MCS scores of 48.9, which were similar to the normative mean of 50 (SD=10) for the US adult population (Figure 1 ). Table 2 ). The specificities of recommended cutoff scores for the MH domain and MCS for the risk of MDD were 77.8% and 76.1%; the sensitivities were 84.9% and 88.1%.
• Based on the AUC, the predictive value of the MH domain and MCS scales using a PHQ-9 score of ≥10 for the total sample was similar ( Table 2 ).
• ROC curves for the entire range of MH domain and MCS scores against the PHQ-9 scores are shown in Figure 2 . • When the same cut-off scores were applied, results for both the MH domain and MCS cut-off scores in the chronic pain subpopulation were similar to those for the total sample (Table 3a) . • To determine if sample-specific cut-off scores would provide better specificity and sensitivity, cut-off scores for the chronic pain subpopulation were determined. Based on a PHQ-9 score of ≥10, the cut-off scores in the participants with chronic pain for the MH and MCS were 40.4 and 43.1, respectively ( Table 3 ). The specificities of recommended cut-off scores for the MH domain and MCS were 77.9% and 73.9%; the sensitivities were 78.3% and 83.4% (Table 3b ). 
Limitations
• All data from the NHWS were self-reported, in English language only, and no verification of diagnoses (chronic pain, depression, or otherwise) was possible.
• The SF-36v2 was not designed to measure depression and should not replace clinical judgment.
• Depression was assessed from the PHQ-9 rather than from a clinician interview directly. This could have introduced additional measurement error.
• The NHWS is broadly representative of the adult US population with respect to core demographic variables, but other variables (e.g., health attitudes, health engagement) may differ.
Conclusions
• In a representative sample of the US general population, this study found that SF-36v2 MH domain and MCS scores are good predictors of major depression.
• MH domain scores at or below 43.0 and MCS scores at or below 46.0 seem to indicate risk for major depressive disorder.
These thresholds maximized the sensitivity and specificity of the measures using ROC analyses.
• If no depression questionnaire is available, it is feasible to use the SF-36v2, a widely used measure to assess health status, to better characterize the mental health of populations. 
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